An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
Conditions: SARS-CoV-2 Infection; COVID-19; Moderate and Severe COVID-19 Interventions: Other: Standard of Care (SoC); Drug: Remdesivir Sponsors: Professor Dr. Bernd Mühlbauer; Dept. of Statistics and Medical Biometry, University of Bremen; INSERM (Institut national de la santé et de la recherche médicale), Paris, France; World Health Organization (WHO), R&D Blueprint, Geneva, Switzerland Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: COVID-19 | France Health | Germany Health | International Medicine & Public Health | Research | SARS | Statistics | Switzerland Health | WHO